Third Quarter 2017 Conference Call Set for November 2nd
Oct 17, 2017
Accelerate Diagnostics, Inc. will announce third quarter 2017 financial results at the close of U.S. financial markets on Thursday, November 2, 2017. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call that same day to review financial results and commercial progress at 4:15 p.m. ET.
- Accelerate Diagnostics, Inc. announced the election of Charles Watts, M.D. to the company’s board of directors. His appointment is effective November 14, 2017.
Nov 16, 2017
- New from LabRoots: Dr. Margie Morgan to present on the impact of fast phenotypic susceptibility results to laboratory workflow and patient outcomes
Nov 09, 2017